Company / FCF Margin
Voyager Therapeutics, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
29.9%
FY2025
5-year range
-147.4% / 39.2%
FY2021-FY2025
Trend
+181.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -644.7% in FY2019 to 232.3% in FY2017.
Based on SEC 10-K filings.
29.9% in FY2025 with a 5-year CAGR of +294.9%.
Improved from -147.4% to 29.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +93.5pp
- 5-Year Change
- +294.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 181.4% year-over-year.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 29.9% | +181.4% |
| FY2024 | -36.7% | +75.1% |
| FY2023 | -147.4% | -131.7% |
| FY2022 | -63.6% | -262.1% |
| FY2021 | 39.2% | +114.8% |
| FY2020 | -265.0% | +58.9% |
| FY2019 | -644.7% | -92.9% |
| FY2018 | -334.1% | -243.8% |
| FY2017 | 232.3% | +370.2% |
| FY2016 | -86.0% | +61.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026